Dermatology
Article
Sacral blistering
Article
Newborn with white oral lesions
Article
Spontaneous ecchymoses
The patient’s lifestyle was undoubtedly to blame for the appearance of her skin. The loss of her beloved pet may have been a tipping point.
Article
Velvety brown lesion
News
Dupilumab study outlines benefits, safety profile in infants, preschoolers with atopic dermatitis
The study was the basis of the Food and Drug Administration expanded approval of dupilumab in June 2022, to include children aged 6 months to 5...
News
Expert makes the case for not subtyping patients with rosacea
“The idea now is to take a phenotypic approach to rosacea,” Dr. Julie Harper advises.
News
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Researchers show that a majority of the authors of the most recent psoriatic arthritis clinical practice guidelines from the American College of...
Article
Recurrent drainage from an old gunshot wound
News
52-week data show lebrikizumab atopic dermatitis effects maintained
ADvocate1 and ADvocate2 are two of several phase 3 trials evaluating the efficacy and safety of lebrikizumab for the treatment of atopic...
News
Ruxolitinib repigments many vitiligo-affected body areas
Ruxolitinib is a Janus kinase 1/2 inhibitor that has been available for the treatment for atopic dermatitis for more than a year.